{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:47:20Z","timestamp":1793213240413,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Pharmacy Department of the Centre int\u00e9gr\u00e9 universitaire de sant\u00e9 et de services sociaux de l\u2019Est-de-l\u2019\u00cele-de-Montr\u00e9al"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00520-021-06734-4","type":"journal-article","created":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:03:13Z","timestamp":1641600193000},"page":"3389-3399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A randomized double-blind feasibility study comparing cetirizine and diphenhydramine in the prevention of paclitaxel-associated infusion-related reactions: the PREMED-F1 study"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8700-7728","authenticated-orcid":false,"given":"Johannie","family":"Beaucage-Charron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lamothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clo\u00e9","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"P\u00e9pin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Lordkipanidz\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Projean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,8]]},"reference":[{"key":"6734_CR1","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1200\/jco.1990.8.7.1263","volume":"8","author":"RB Weiss","year":"1990","unstructured":"Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL et al (1990) Hypersensitivity reactions from taxol. J Clin Oncol 8:1263\u20131268. https:\/\/doi.org\/10.1200\/jco.1990.8.7.1263","journal-title":"J Clin Oncol"},{"key":"6734_CR2","first-page":"1171","volume":"71","author":"RC Donehower","year":"1987","unstructured":"Donehower RC, Rowinsky EK, Grochow LB, Longnecker SM, Ettinger DS (1987) Phase I trial of taxol in patients with advanced cancer. Cancer Treat Rep 71:1171\u20131177","journal-title":"Cancer Treat Rep"},{"key":"6734_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12016-014-8416-0","volume":"49","author":"M Picard","year":"2015","unstructured":"Picard M, Castells MC (2015) Re-visiting hypersensitivity reactions to taxanes: a comprehensive review. Clin Rev Allergy Immunol 49:177\u2013191. https:\/\/doi.org\/10.1007\/s12016-014-8416-0","journal-title":"Clin Rev Allergy Immunol"},{"key":"6734_CR4","unstructured":"Pfizer Canada ULC (2020) Product monograph: paclitaxel for injection"},{"key":"6734_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.iac.2017.07.004","volume":"37","author":"M Picard","year":"2017","unstructured":"Picard M (2017) Management of hypersensitivity reactions to taxanes. Immunol Allergy Clin North Am 37:679\u2013693. https:\/\/doi.org\/10.1016\/j.iac.2017.07.004","journal-title":"Immunol Allergy Clin North Am"},{"key":"6734_CR6","unstructured":"Pharmaceutical Partners of Canada Inc (2012) Package insert: Diphenhydramine hydrochloride injection USP"},{"key":"6734_CR7","doi-asserted-by":"crossref","unstructured":"Estelle R, Simons F, Akdis CA (2008) Histamine and H1 Antihistamines. In: Franklin Adkinson Jr N, Busse W, Bochner B, Holgate S, Estelle Simons F, Lemanske R (ed) Middleton\u2019s Allergy: Principles and Practice, 7th edn. Elsevier Health Sciences, pp 1517\u20131548","DOI":"10.1016\/B978-0-323-05659-5.00087-5"},{"key":"6734_CR8","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/s0091-6749(05)80246-5","volume":"86","author":"J Kalivas","year":"1990","unstructured":"Kalivas J, Breneman D, Tharp M, Bruce S, Bigby M (1990) Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. J Allergy Clin Immunol 86:1014\u20131018. https:\/\/doi.org\/10.1016\/s0091-6749(05)80246-5","journal-title":"J Allergy Clin Immunol"},{"key":"6734_CR9","first-page":"191","volume":"64","author":"S Belaich","year":"1990","unstructured":"Belaich S, Bruttmann G, DeGreef H, Lachapelle JM, Paul E, Pedrali P et al (1990) Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Ann Allergy 64:191\u2013194","journal-title":"Ann Allergy"},{"key":"6734_CR10","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/0091-6749(90)90091-H","volume":"86","author":"FE Simons","year":"1990","unstructured":"Simons FE, McMillan JL, Simons KJ (1990) A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppresive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 86:540\u2013547","journal-title":"J Allergy Clin Immunol"},{"key":"6734_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13223-019-0375-9","volume":"15","author":"MN Fein","year":"2019","unstructured":"Fein MN, Fischer DA, O\u2019Keefe AW, Sussman GL (2019) CSACI position statement: newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria. Allergy Asthma Clin Immunol 15:1\u20136. https:\/\/doi.org\/10.1186\/s13223-019-0375-9","journal-title":"Allergy Asthma Clin Immunol"},{"key":"6734_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/jppr2002322108","volume":"32","author":"J Siderov","year":"2002","unstructured":"Siderov J, Wendel N, Davis ID (2002) Non-sedating antihistamines for premedication in ambulatory oncology patients. J Pharm Pract Res 32:108\u2013109. https:\/\/doi.org\/10.1002\/jppr2002322108","journal-title":"J Pharm Pract Res"},{"key":"6734_CR13","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1177\/1078155218811505","volume":"25","author":"CG Durham","year":"2019","unstructured":"Durham CG, Thotakura D, Sager L, Foster J, Herrington JD (2019) Cetirizine versus diphenhydramine in the prevention of chemotherapy-related hypersensitivity reactions. J Oncol Pharm Pract 25:1396\u20131401. https:\/\/doi.org\/10.1177\/1078155218811505","journal-title":"J Oncol Pharm Pract"},{"key":"6734_CR14","unstructured":"National Institutes of Health, National Cancer Institute (2017) Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0"},{"key":"6734_CR15","unstructured":"McNeil Consumer Healthcare (2017) Product monograph: reactine, reactine fast melt junior, reactine rapid dissolve, reactine allergy liquid gels"},{"key":"6734_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1034\/j.1398-9995.1999.00038.x","volume":"54","author":"LJ Petersen","year":"1999","unstructured":"Petersen LJ, Church MK, Rihoux JP, Skov PS (1999) Measurement of interstitial cetirizine concentrations in human skin: correlation of drug levels with inhibition of histamine-induced skin responses. Allergy 54:607\u2013611. https:\/\/doi.org\/10.1034\/j.1398-9995.1999.00038.x","journal-title":"Allergy"},{"key":"6734_CR17","doi-asserted-by":"publisher","first-page":"e630","DOI":"10.3747\/co.21.1966","volume":"21","author":"J Boulanger","year":"2014","unstructured":"Boulanger J, Boursiquot JN, Cournoyer G, Lemieux J, Masse MS, Almanric K et al (2014) Management of hypersensitivity to platinum- and taxane-based chemotherapy: CEPO review and clinical recommendations. Curr Oncol 21:e630-641. https:\/\/doi.org\/10.3747\/co.21.1966","journal-title":"Curr Oncol"},{"key":"6734_CR18","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2500\/aap.2007.28.3015","volume":"28","author":"A Banerji","year":"2007","unstructured":"Banerji A, Long AA, Camargo CA (2007) Diphenhydramine versus nonsedating antihistamines for acute allergic reactions: a literature review. Allergy Asthma Proc 28:418\u2013426. https:\/\/doi.org\/10.2500\/aap.2007.28.3015","journal-title":"Allergy Asthma Proc"},{"key":"6734_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.biopha.2017.06.008","volume":"93","author":"P Pasko","year":"2017","unstructured":"Pasko P, Rodacki T, Domagala-Rodacka R, Palimonka K, Marcinkowska M, Owczarek D (2017) Second generation H1 - antihistamines interaction with food and alcohol\u2014a systematic review. Biomed Pharmacother 93:27\u201339. https:\/\/doi.org\/10.1016\/j.biopha.2017.06.008","journal-title":"Biomed Pharmacother"},{"key":"6734_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1469-8986.1973.tb00801.x","volume":"10","author":"E Hoddes","year":"1973","unstructured":"Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC (1973) Quantification of sleepiness: a new approach. Psychophysiology 10:431\u2013436. https:\/\/doi.org\/10.1111\/j.1469-8986.1973.tb00801.x","journal-title":"Psychophysiology"},{"key":"6734_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.2002.384.doc.x","volume":"10","author":"GA Lancaster","year":"2004","unstructured":"Lancaster GA, Dodd S, Williamson PR (2004) Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract 10:307\u2013312. https:\/\/doi.org\/10.1111\/j.2002.384.doc.x","journal-title":"J Eval Clin Pract"},{"key":"6734_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1471-2288-13-104","volume":"13","author":"SA Billingham","year":"2013","unstructured":"Billingham SA, Whitehead AL, Julious SA (2013) An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database. BMC Med Res Methodol 13:104. https:\/\/doi.org\/10.1186\/1471-2288-13-104","journal-title":"BMC Med Res Methodol"},{"key":"6734_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/pst.185","volume":"4","author":"S Julious","year":"2005","unstructured":"Julious S (2005) Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat 4:287\u2013291. https:\/\/doi.org\/10.1002\/pst.185","journal-title":"Pharm Stat"},{"key":"6734_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150205","volume":"11","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Lancaster GA, Campbell MJ, Thabane L, Hopewell S, Coleman CL et al (2016) Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PLoS ONE 11:e0150205. https:\/\/doi.org\/10.1371\/journal.pone.0150205","journal-title":"PLoS ONE"},{"key":"6734_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015276","volume":"7","author":"SJ Walters","year":"2017","unstructured":"Walters SJ, Dos Anjos B, Henriques-Cadby I, Bortolami O, Flight L, Hind D, Jacques RM et al (2017) Recruitment and retention of participants in randomised controlled trials: a review of trial funded and published by the United Kingdom Health Technology Assessment Programme. BMJ Open 7:e015276. https:\/\/doi.org\/10.1136\/bmjopen-2016-015276","journal-title":"BMJ Open"},{"key":"6734_CR26","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1200\/jco.2005.03.8976","volume":"24","author":"N Avis","year":"2006","unstructured":"Avis N, Smith K, Link C, Hortobagyi GN, Rivera E (2006) Factors associated with participation in breast cancer clinical trials. J Clin Oncol 24:1860\u20131867. https:\/\/doi.org\/10.1200\/jco.2005.03.8976","journal-title":"J Clin Oncol"},{"key":"6734_CR27","doi-asserted-by":"publisher","first-page":"s622","DOI":"10.1067\/mai.2000.106153","volume":"105","author":"GG Kay","year":"2000","unstructured":"Kay GG (2000) The effects of antihistamines on cognition and performance. J Allergy Clin Immunol 105:s622-627. https:\/\/doi.org\/10.1067\/mai.2000.106153","journal-title":"J Allergy Clin Immunol"},{"key":"6734_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijerph8010015","volume":"8","author":"J Efird","year":"2011","unstructured":"Efird J (2011) Blocked randomization with randomly selected block sizes. Int J Environ Res Public Health 8:15\u201320. https:\/\/doi.org\/10.3390\/ijerph8010015","journal-title":"Int J Environ Res Public Health"},{"key":"6734_CR29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/sleep\/27.3.541","volume":"27","author":"CC Maldonado","year":"2004","unstructured":"Maldonado CC, Bentley AJ, Mitchell D (2004) A pictorial sleepiness scale based on cartoon faces. Sleep 27:541\u2013548. https:\/\/doi.org\/10.1093\/sleep\/27.3.541","journal-title":"Sleep"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06734-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-021-06734-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06734-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T13:28:44Z","timestamp":1744118924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-021-06734-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,8]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["6734"],"URL":"https:\/\/doi.org\/10.1007\/s00520-021-06734-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,8]]},"assertion":[{"value":"15 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Comit\u00e9 d\u2019\u00c9thique de la Recherche de l\u2019H\u00f4pital Maisonneuve-Rosemont, Centre int\u00e9gr\u00e9 universitaire de sant\u00e9 et de services sociaux de l\u2019Est-de-l\u2019\u00cele-de-Montr\u00e9al (17.01.2020, #2020\u20132110).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article. Marie Lordkipanidz\u00e9 was supported by the Fonds de recherche du Qu\u00e9bec en Sant\u00e9 Junior 1 Research Scholarship (33048) and is a Canada Research Chair in Platelets as biomarkers and vectors (950\u2013232706).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}